MedicQuant, a spinout from iNANO and the Department of Chemistry at Aarhus University, has secured new seed funding to advance a diagnostic platform rooted in more than 11 years of research. Built on DNA nanotechnology, the company’s point-of-care system aims to deliver rapid, laboratory-accurate drug measurements in acute clinical settings.

iNANO Professor Daniel Otzen is part of the new DESYNA project, which has received DKK 26.7 million from Innovation Fund Denmark to develop a novel therapy for Parkinson’s disease. The project aims to target and remove toxic alpha-synuclein aggregates that drive disease progression and spread in the brain.

In March 2026, the SDC Ideathon in Beijing brought together more than 150 master’s students for 36 hours of transdisciplinary innovation. The event was co-organised by Morten Foss from iNANO (Aarhus University), while Nanoscience student Line Grølsted (also from Aarhus University) was part of one of the two winning teams.